Challenges of COVID-19 in children in low- and middle-income countries

Heather J Zar1, Jeanette Dawa2, Gilberto Bueno Fischer3

  • 1Department of Paediatrics and Child Health, SA MRC Unit on Child and Adolescent Health, Red Cross Children's Hospital, University of Cape Town, Cape Town, South Africa.

Insights

The coronavirus disease (COVID-19) pandemic disproportionately affects children in low- and middle-income countries (LMICs) through indirect health impacts. Addressing these challenges can strengthen child health systems in LMICs.

Area of Science:

  • Global Health
  • Infectious Diseases
  • Pediatrics

Background:

  • The COVID-19 pandemic's impact extends to low- and middle-income countries (LMICs), raising concerns about comorbidities, health systems, and economies.
  • Children in LMICs, though often asymptomatic to COVID-19, face risks from comorbidities and resource diversion from child health services.
  • Poor living conditions and limited public health infrastructure in LMICs exacerbate SARS-CoV-2 transmission and impact child health.

Purpose of the Study:

  • To analyze the multifaceted impact of the COVID-19 pandemic on child health in LMICs.
  • To identify challenges in implementing public health measures and protecting healthcare workers in LMICs.
  • To explore opportunities for strengthening child health systems in LMICs amidst the pandemic.

Main Methods:

  • This study is a review and analysis of the existing literature and reports on the impact of the COVID-19 pandemic on child health in LMICs.
  • The analysis focuses on direct and indirect effects, health system capacity, and public health measure implementation.
  • Key challenges and potential opportunities for improving child health services are identified.

Main Results:

  • Children in LMICs face significant indirect health consequences, including poverty, disrupted education, and interrupted health programs.
  • Implementing effective public health measures like social distancing and mask-wearing is challenging in LMICs due to resource constraints and living conditions.
  • Healthcare workers in LMICs face risks due to inadequate personal protective equipment.

Conclusions:

  • The COVID-19 pandemic highlights global health inequities and poses substantial indirect risks to child health in LMICs.
  • Strengthening child health programs and addressing systemic challenges are crucial for mitigating the pandemic's long-term effects in LMICs.
  • The crisis presents opportunities to build more resilient and equitable health systems for children in LMICs.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
133
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
178
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
149
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.8K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
115